New England Surgical Society (NESS)
Search NESS
  Annual Meeting
  Annual Resident and Fellow Research Day
      Member Directory
      Members Only
  Scholars Foundation
  Job Board
  Journal of the American College of Surgeons
  Contact NESS

NESS 2006 Annual Meeting
Back to Scientific Program
Back to Annual Meeting

National Trends in the Treatment of Upper GI Bleed
Joshua S Hill, James T McPhee, Frederick A Anderson, Waheed Y Wassef, Sridhar Shankar, Demetrius E Litwin, Jennifer F Tseng
University of Massachusetts, Worcester, MA

Objective: The management of upper GI bleed (UGIB) encompasses multiple disciplines including Gastroenterology, Radiology and Surgery. This study examined, at a national level, the frequency of procedural treatment of UGIB by these specialties.
Design: Retrospective survey.
Setting: Hospital inpatients.
Patients: Nationwide Inpatient Sample (NIS), a representative all-payer database of US non-federal hospitals (1998-2003). Patients discharged with primary diagnosis of UGIB.
Interventions: 1) expectant management, 2) endoscopic control of bleeding, excluding diagnostic, 3) angiography endoscopy, 4) surgical treatment angiography/endoscopy.
Main Outcome Measure: Frequency (weighted).
Results: 1,072,307 weighted discharges (217,887 unweighted) were identified with the primary diagnosis of UGIB, including expectant management-90.1%, endoscopic control-9.5%, angio-embolization-0.1% and surgery-0.3%. Angio-embolization rates remained constant. In 1998, 4.7% of patients with UGIB were treated operatively, declining subsequently by 0.5%/year (p<0.01). Endoscopic treatment became more prevalent. In 1998, 8.7% of patients were treated by endoscopic means; by 2003 this had increased to 10% (p<0.01). Factors independently associated with surgery included congestive heart failure (OR 1.3, 95% CI 1.04-1.55), age <50 (OR 1.3, 95% CI 1.02-1.60), male sex (OR 1.3, 95% CI 1.10-1.49), private HMO versus Medicare (OR 1.3, 95% CI 1.07-1.54), and being treated in a teaching hospital (OR 1.4, 95% CI 1.20-1.71).
Conclusions: Operative treatment of UGIB has declined. The percentage of total patients with UGIB treated by surgery declined 0.5% per year; the number of patients undergoing surgery in 2003 was 1/3 fewer than in 1998. Many patients now undergo less invasive treatment modalities such as endoscopy.

Back to Scientific Program
Back to Annual Meeting

Copyright © 2020 New England Surgical Society. All Rights Reserved.
Read Privacy Policy.